[Studies on von Willebrand factor antigen in endothelial cells and sera of patients with connective tissue diseases].
Von Willebrand factor antigen (vWF: Ag) is known to be produced and excreted by endothelial cells (EC). The influences of interferon (IFN) on surface, excreted and intracellular vWF: Ag amounts of EC were studied by flow cytometry and ELISA. Serum levels of vWF: Ag in patients with connective tissue diseases were also studied by ELISA. Experiments in vitro showed that IFN increased vWF: Ag amounts of EC. Serum levels of vWF: Ag in patients with mixed connective tissue disease (MCTD), systemic lupus erythematosus, progressive systemic sclerosis, polymyositis/dermatomyositis or rheumatoid arthritis (RA) were significantly higher than those of normal subjects, on the other hand, vWF: Ag levels in patients with aortitis syndrome were within normal range. MCTD patients complicated with pulmonary hypertension (PH) [MCTD (PH)] and RA vasculitis (MRA) patients had quite high levels of vWF: Ag. The levels of vWF: Ag seemed to correlate with severity of PH in patients with MCTD (PH). Increased serum levels of vWF: Ag observed in those patients might be induced by EC damaged or influenced by IFN or other cytokines. Monitoring of vWF: Ag levels could be useful to predict the onset and pathologic conditions of MCTD (PH) or related vascular diseases.
Second Department of Internal Medicine, Fukushima Medical College.
S
S
Kida
D000328:Adult; D004730:Endothelium, Vascular / Q000166:cytology / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005434:Flow Cytometry; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D007372:Interferons / Q000502:physiology; D008947:Mixed Connective Tissue Disease / Q000276:immunology*; D014841:von Willebrand Factor / Q000032:analysis*
D006684:HLA-DR Antigens; D014841:von Willebrand Factor; D007372:Interferons